Get started
Author

Жидкова Екатерина Михайловна

Observed names: E. M Zhidkova, E. M. Zhidkova, E. Zhidkova, E.M. Zhidkova, Ekaterina M Zhidkova, Ekaterina M. Zhidkova, Ekaterina Zhidkova, Zhidkova Ekaterina, Е. М. Zhidkova, Е. М. Жидкова
ORCID: 0000-0003-3318-9391
Observed ORCID: 0000-0003-3318-9391
OpenAlex ID: A5007097663
The long winding road to the safer glucocorticoid receptor (GR) targeting therapies
2022 · Ekaterina A. Lesovaya, Daria Chudakova, et al. · Oncotarget · 44
PDF
Nutritional Sensor REDD1 in Cancer and Inflammation: Friend or Foe?
2022 · Ekaterina M. Zhidkova, Evgeniya S. Lylova, et al. · International Journal of Molecular Sciences · 35
PDF
A Brief Overview of the Paradoxical Role of Glucocorticoids in Breast Cancer
2020 · Ekaterina M Zhidkova, Evgeniya S Lylova, et al. · Breast Cancer Basic and Clinical Research · 29
PDF
Synephrine and Its Derivative Compound A: Common and Specific Biological Effects
2023 · Svetlana A. Dodonova, Ekaterina Zhidkova, et al. · International Journal of Molecular Sciences · 23
PDF
Ultrasonic and microwave activation of raspberry extract: antioxidant and anti-carcinogenic properties
2019 · Natalia Eremeeva, Nadezhda Makarova, et al. · Foods and raw materials · 21
Synthesis and Anti-Cancer Activity of the Novel Selective Glucocorticoid Receptor Agonists of the Phenylethanolamine Series
2024 · Ekaterina M. Zhidkova, Leyla R. Tilova, et al. · International Journal of Molecular Sciences · 11
PDF
A Novel Approach to Safer Glucocorticoid Receptor–Targeted Anti-lymphoma Therapy via REDD1 (Regulated in Development and DNA Damage 1) Inhibition
2020 · Ekaterina A. Lesovaya, Alena V. Savinkova, et al. · Molecular Cancer Therapeutics · 11
Variants and Perspectives of Drug Repurposing for Cancer Treatment
2018 · A. V. Savinkova, E. M. Zhidkova, et al. · Siberian Journal of Oncology · 10
PDF
Influence of the Number of Axial Bexarotene Ligands on the Cytotoxicity of Pt(IV) Analogs of Oxaliplatin
2017 · Yulia N. Nosova, Ilia V. Zenin, et al. · Bioinorganic Chemistry and Applications · 9
PDF
Histone Methyltransferases as a New Target for Epigenetic Action of Vorinostat
2023 · Varvara Maksimova, Julia Makus, et al. · Biochemistry (Moscow) · 8
PDF
Synthetic 1,2,4-triazole-3-carboxamides Induce Cell Cycle Arrest and Apoptosis in Leukemia Cells
2023 · Zhidkova Ekaterina, Stepanycheva Daria, et al. · Current Pharmaceutical Design · 7
Synthesis of Alkyl/Aryloxymethyl Derivatives of 1,2,4-Triazole-3-Carboxamides and Their Biological Activities
2024 · Ekaterina Mikhina, Daria Stepanycheva, et al. · Molecules · 6
Comparative Analysis of Biological Effects of Selective Activator of the Glucocorticoid Receptor Cpda on Different Subtypes of Breast Cancer Cell Lines
2017 · E. M. Zhidkova, K. A. Kuzin, et al. · Siberian Journal of Oncology · 6
PDF
Modern approaches for the screening of epigenetically active xenobiotics
2019 · V. P. Maksimova, P. E. Bugaeva, et al. · Advances in molecular oncology · 5
PDF
Marine-Derived Steroids for Cancer Treatment: Search for Potential Selective Glucocorticoid Receptor Agonists/Modulators (SEGRAMs)
2025 · Ekaterina M. Zhidkova, Ekaterina D. Savina, et al. · Marine Drugs · 4
PDF
Side effects of glucocorticoids: in vivo models and underlying mechanisms
2025 · Svetlana A. Dodonova, Ekaterina M. Zhidkova, et al. · Discover Medicine · 4
PDF
Synthesis and Anti-Cancer Activity In Vitro of Synephrine Derivatives
2024 · Ekaterina M. Zhidkova, Evgeniya S. Oleynik, et al. · Biomolecules · 4
PDF
Insights into the Mechanism of Curaxin CBL0137 Epigenetic Activity: The Induction of DNA Demethylation and the Suppression of BET Family Proteins
2023 · Varvara Maksimova, Valeriia Popova, et al. · International Journal of Molecular Sciences · 4
PDF
Aberrations of DNA methylation in cancer
2022 · V. P. Maksimova, O. G. Usalka, et al. · Advances in molecular oncology · 4
PDF
Secreted cyclophilin A is non-genotoxic but acts as a tumor promoter
2023 · Anastasiia Kalinina, Leila Tilova, et al. · Toxicology · 3
Anti-tumor Effect of Cpda Enantiomers in Vitro in the Model of Acute Lymphoblastic Leukemia
2017 · A. V. Savinkova, L. R. Tilova, et al. · Russian Journal of Biotherapy · 3
PDF
Selective glucocorticoid receptor agonists as an alternative to glucocorticoids in the treatment of acute lymphoblastic leukemia: clinical response to glucocorticoids compared with molecular effects in vitro
2025 · O. A. Vlasova, E. M. Zhidkova, et al. · Oncohematology · 2
PDF
Endocrine disruptors as promoters of biosphere carcinogenic background
2023 · G. A. Belitsky, K. I. Kirsanov, et al. · Siberian Journal of Oncology · 2
PDF
Inhibition of glucocorticoid-induced REDD1 expression by rapamycin in breast cancer cells
2022 · D. D. Grigorieva, E. M. Zhidkova, et al. · Advances in molecular oncology · 2
PDF
Inhibition of Redd1 Expression for the Reduction of Glucocorticoid-induced Side Effects
2020 · E. S. Lylova, A. V. Savinkova, et al. · Siberian Journal of Oncology · 2
PDF
Works count: 55
Citation count: 265
H-index: 9
I10-index: 8
Year
Topic
Type